Marinus Pharmaceuticals Inc
NASDAQ:MRNS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Marinus Pharmaceuticals Inc
NASDAQ:MRNS
|
US |
|
E
|
Essential Utilities Inc
XBER:A2A
|
US |
|
S
|
Subsea 7 SA
SWB:SOC
|
UK |
|
R
|
Rupert Resources Ltd
OTC:RUPRF
|
CA |
|
Fomento Economico Mexicano SAB de CV
LSE:0TD7
|
MX |
|
Biogaia AB
F:BGLA
|
SE |
|
Crane Co
F:T12
|
US |
|
Grupo Aeroportuario del Pacifico SAB de CV
F:G9N
|
MX |
|
Swedbank AB
F:FRY
|
SE |
|
E
|
Extreme Networks Inc
SWB:EXM
|
US |
Shareholder Yield
Current shareholder yield for
MRNS is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
MRNS Price
Marinus Pharmaceuticals Inc
| Average Annual Return | 15.1% |
| Standard Deviation of Annual Returns | 113.64% |
| Max Drawdown | -99% |
| Market Capitalization | 30.4m USD |
| Shares Outstanding | 55 220 000 |
| Percentage of Shares Shorted | 10.32% |
MRNS Return Decomposition
Main factors of price return
Stock Splits
MRNS's latest stock split occurred on Sep 23, 2020
The company executed a 1-for-4 stock split, meaning that for every 4 shares held, investors received 1 new share.
Before the split, MRNS traded at 3.14 per share. Afterward, the share price was about 12.01.
The adjusted shares began trading on Sep 23, 2020. This was the only stock split in MRNS's history.